Meet the MedCity Media Team

And take 2 minutes to help us make MedCityNews.com better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Ohio State hires cancer researcher from Georgetown University

4:16 pm by | 0 Comments

Dr. Peter Shields

The Ohio State University Comprehensive Cancer Center has hired a new deputy director, a top cancer researcher from Georgetown University. 

Dr. Peter Shields‘s primary research focus has been in identifying biomarkers that can be used to assess breast and lung cancer risks, particularly those related to diet, smoking and lifestyle, according to a statement from the Ohio State University Medical Center. A biomarker is a protein found in the blood that can indicate the presence or severity of a certain disease. 

“The more markers we identify, the more aggressive screening and monitoring we can do for people with those markers, and we can also focus better our behavioral interventions and chemoprevention,” Shields said. 

Advertisement

Shields was recently named the president of the American Society of Preventive Oncology and has published more than 180 studies. 

At OSU, he’ll oversee the cancer center’s research program, which includes more than 270 cancer researchers from 11 of OSU’s 14 colleges. 

In addition to the deputy director role, Shields will also be a professor in OSU’s department of internal medicine. 

At Georgetown, Shields was deputy director of the Lombardi Comprehensive Cancer Center

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Brandon Glenn

By Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.
More posts by Author

0 comments

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement